← Leaderboards
Bilal Bin Hafeez
University Of Texas Rio Grande Valley
$1,453,000
Attributed
$1,453,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $363.3K · FY2021–24$500K$375K$250K$125K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$1,453,000 · 1
By mechanism
SC1$1,453,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Rio Grande Valley
Same institution · by research overlap
- Megan E Keniry$731,900
Others in their field
Other Emerging Leaders on “Desmoplastic”
- Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor$2,792,961
- Ajit Harishkumar Goenka · University Of California, San Francisco$2,539,832
- Gabi Hanna · Lamassu Pharma Inc.$2,027,310
- Gulam Abbas Manji · Columbia University Health Sciences$1,946,398
- Filemon S Dela Cruz · Sloan-Kettering Inst Can Research$1,826,092
- Sean B Lee · Tulane University Of Louisiana$1,735,100
Research focus
DesmoplasticAdenocarcinoma4-Methylumbelliferone3-DimensionalAnti-CancerAntitumor EffectAdvanced Pancreatic CancerBiogenesisBioluminescence ImagingAffectCancer EtiologyCancer TherapyCatalytic DomainCell CycleCell PhysiologyCellsCessation Of LifeChemoresistanceChemosensitizationChemotherapyClinicCancer CellComplexDisease Progression
Grant awards (4)
Targeting ribosome biogenesis and desmoplastic tumor microenvironment for the treatment of advanced pancreatic cancer$363,250
SC1 · FY2024 · GM · contact PI
Targeting ribosome biogenesis and desmoplastic tumor microenvironment for the treatment of advanced pancreatic cancer$363,250
SC1 · FY2023 · GM · contact PI
Targeting ribosome biogenesis and desmoplastic tumor microenvironment for the treatment of advanced pancreatic cancer$363,250
SC1 · FY2022 · GM · contact PI
Targeting ribosome biogenesis and desmoplastic tumor microenvironment for the treatment of advanced pancreatic cancer$363,250
SC1 · FY2021 · GM · contact PI